Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Are patients suffering from stable angina receiving optimal medical treatment
Autore:
Beaulieu, MD; Blais, R; Jacques, A; Battista, RN; Lebeau, R; Brophy, J;
Indirizzi:
Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ H2L 4M1, Canada Univ Montreal Montreal PQ Canada H2L 4M1 tr, Montreal, PQ H2L 4M1, Canada Univ Montreal, Dept Family Med, GRIS, Montreal, PQ H2L 4M1, Canada Univ Montreal Montreal PQ Canada H2L 4M1 IS, Montreal, PQ H2L 4M1, Canada Univ Montreal, Dept Hlth Adm, Montreal, PQ H2L 4M1, Canada Univ Montreal Montreal PQ Canada H2L 4M1 dm, Montreal, PQ H2L 4M1, Canada McGill Univ, Montreal, PQ, Canada McGill Univ Montreal PQ CanadaMcGill Univ, Montreal, PQ, Canada Coll Med, Practice Enhancement Div, Quebec City, PQ, Canada Coll Med Quebec City PQ Canada Enhancement Div, Quebec City, PQ, Canada McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada McGillUniv Montreal PQ Canada H3A 2T5 stat, Montreal, PQ H3A 2T5, Canada
Titolo Testata:
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
fascicolo: 6, volume: 94, anno: 2001,
pagine: 301 - 308
SICI:
1460-2725(200106)94:6<301:APSFSA>2.0.ZU;2-1
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; THERAPY; QUALITY; CARE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
22
Recensione:
Indirizzi per estratti:
Indirizzo: Beaulieu, MD Univ Montreal, Ctr Hosp, Res Ctr, Pavillon Louis Charles Simard,Pavillon Notre Dame, Montreal, PQ H2L 4M1, Canada Univ Montreal PavillonLouis Charles Simard,Pavillon Notre Dame Montreal PQ Canada H2L 4M1
Citazione:
M.D. Beaulieu et al., "Are patients suffering from stable angina receiving optimal medical treatment", QJM-MON J A, 94(6), 2001, pp. 301-308

Abstract

There is good evidence for the use of antiplatelet, beta-blocker and lipid-lowering drugs in the treatment of ischaemic heart disease, but few data on how these medications are used in treating stable angina pectoris. We examined prescription profiles for a sample of patients aged greater than or equal to 65 years with stable angina, to compare the profiles to local guidelines and to explore the determinants of these profiles, in a cross-sectional study. We identified 11 141 individuals from the Quebec provincial out-patient pharmaceutical database for the period 1 lune 1996 to 31 May 1997, and examined the percentage of these patients with and without associated co-morbidities receiving antiplatelet, beta-blocker and lipid-lowering medications. We used hierarchical modelling to examine the role of patient and physician characteristics in explaining the variation in the use of these medications. Calcium-channel blockers were the class of anti-ischaemic drugs most prescribed (63%). Beta-blockers were prescribed in 52.1% of patients. Antiplatelet and lipid-lowering drugs were prescribed to 56.8% and 32.6%, respectively. increasing age and female gender made patients less likely to be prescribed these treatments. General practitioners were less likely than cardiologists to prescribe beta-blockers and lipid-lowering drugs (OR 0.79,C1 95% 0.68-0.91 and OR 0.77, CI 95% 0.66-0.91,respectively). There is a general under-use of antiplatelet, beta-blocker and lipid-lowering medications in the treatment of stable angina pectoris patients, ical modelling to examine the role of patient and possibly leading to adverse patient outcomes.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/20 alle ore 07:27:05